Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence

• Status: Completed
• Trial end date: 2012-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine if a new drug treatment is effective for the treatment of symptoms of urinary incontinence.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beech Tree Labs, Inc.
• Collaborator: Norwich Clinical Research Associates Ltd.

Criteria

Inclusion Criteria:

• Women who have moderate to severe urge, stress or mixed Urinary Incontinence

Exclusion Criteria:

• Medical history of migraines, neurologic problems, swallowing disorder, stroke or severe depression.

• Medical history of heart failure, peripheral edema or moderate to severe asthma or chronic obstructive pulmonary disease (COPD)

• Certain restricted medications

• Any other condition that would interfere with the safety of the subject